New‐onset lung sarcoidosis, an adverse event by COVID‐19 or a sign of convalescence; a case report
Key Clinical Message Sarcoidosis is a systemic inflammatory disease able to affect any organ within the body. Sarcoidosis may be the body's secondary response to COVID‐19 infection and a sign of rehabilitation. Early response to the treatments reinforces this hypothesis. The majority of sarcoid...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7339 |